Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs
Open Access
- 1 August 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (4), 439-445
- https://doi.org/10.1038/bjc.1998.512
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Immunomodulatory Actions of Xanthenone Anticancer AgentsBioDrugs, 1997
- Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: HYPOXIA‐ACTIVATED PRODRUGS AS ANTITUMOUR AGENTS: STRATEGIES FOR MAXIMIZING TUMOUR CELL KILLINGClinical and Experimental Pharmacology and Physiology, 1995
- Hypoxia-Selective Antitumor Agents. 9. Structure-Activity Relationships for Hypoxia-Selective Cytotoxicity among Analogs of 5-[N,N-Bis(2-chloroethyl)amino]-2,4-dinitrobenzamideJournal of Medicinal Chemistry, 1994
- Enhancement of radioimmunotherapy by drugs modifying tumour blood flow in a colonic xenograft modelInternational Journal of Cancer, 1994
- The morphological effects of the anti–tumor agents flavone acetic acid and 5,6–dimethyl xanthenone acetic acid on the colon 38 mouse tumorPathology, 1994
- Hyper-responsiveness to 5-HT2Agonists by Tumour-linked Arterioles in Mice: Consequences for Tumour GrowthInternational Journal of Radiation Biology, 1991
- Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acidEuropean Journal of Cancer and Clinical Oncology, 1990
- Synthesis and evaluation of .alpha.-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of .alpha.-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxinsJournal of Medicinal Chemistry, 1990
- Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour actionEuropean Journal of Cancer and Clinical Oncology, 1989
- Flavone acetic acid—Preclinical and clinical activityEuropean Journal of Cancer and Clinical Oncology, 1989